1292211-01-8

Basic information

• Product Name: ethyl 2-((tert-butoxycarbonylamino)methyl)-5-fluorobenzoate
• Synonyms: ethyl 2-((tert-butoxycarbonylamino)methyl)-5-fluorobenzoate
• CAS NO: 1292211-01-8
• Molecular Weight: 297.327
• Mol File: 1292211-01-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: ethyl 2-((tert-butoxycarbonylamino)methyl)-5-fluorobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-((tert-butoxycarbonylamino)methyl)-5-fluorobenzoate(1292211-01-8)
• EPA Substance Registry System: ethyl 2-((tert-butoxycarbonylamino)methyl)-5-fluorobenzoate(1292211-01-8)

Safety Data

• Hazardous Substances Data: 1292211-01-8(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 1260751-65-2 ethyl 2-cyano-5-fluorobenzoate 
• 139911-28-7 ethyl 2-bromo-5-fluorobenzoate 

Downstream Products

• 1292211-02-9 2-(aminomethyl)-5-fluorobenzoic acid ethyl ester hydrochloride 

Relevant articles and documents

Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus

This invention concerns to naphthyridin derivatives of formula (I) for use in the treatment or prevention of feline immunodeficiency virus (FIV). Furthermore the present invention relates to a method of treating or preventing infection of feline immunodeficiency virus in a feline animal wherein said method comprises the administration to said feline animal of a therapeutically effective amount of a naphthyridin derivative.

MACROCYCLIC INTEGRASE INHIBITORS

Compound having formula (I), wherein - W is NH-, -N(CH3)- or piperazine, - X is a bond, -C(=O)- or S(=O)2-, - Y is C3-7alkylene, and - Z is NH-C(=O)- or -O-, and pharmaceutically acceptable salts thereof, their pharmaceutical formulations and use as HIV inhibitors.